Free Trial
LON:CREO

Creo Medical Group (CREO) Share Price, News & Analysis

Creo Medical Group logo

About Creo Medical Group Stock (LON:CREO)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
13.50
20.40
52-Week Range
N/A
Volume
599,559 shs
Average Volume
809,775 shs
Market Capitalization
£56.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The Company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes. Kamaptive is a seamless, intuitive integration of multi-modal energy sources, optimised to dynamically adapt to patient tissue during procedures such as resection, dissection, coagulation and ablation of tissue. Kamaptive technology provides clinicians with increased flexibility, precision and controlled surgical solutions. CROMA currently delivers bipolar radiofrequency ("RF") energy for precise localised cutting and focused high frequency microwave ("MW") energy for controlled coagulation and ablation via a single accessory port. This technology, combined with the Group's range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions. The Directors believe the Company's technology can impact the landscape of surgery and endoscopy by providing a safer, less-invasive and more cost-efficient option for procedures. For more information, please refer to the website www.creomedical.com

Remove Ads
Receive CREO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter.

CREO Stock News Headlines

Trump doesn’t give a damn
Porter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met with one of Trump’s longest-serving advisors. We helped put together a plan to help investors capitalize on Trump’s election. And we found out these 10 stocks are the most likely to boom…
See More Headlines

CREO Stock Analysis - Frequently Asked Questions

Creo Medical Group PLC (LON:CREO) posted its quarterly earnings results on Tuesday, October, 1st. The company reported ($0.03) EPS for the quarter. Creo Medical Group had a negative trailing twelve-month return on equity of 41.79% and a negative net margin of 73.93%.

Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Creo Medical Group investors own include Aviva (AV), IQE (IQE), Lloyds Banking Group (LLOY), Barclays (BARC), BP (BP), BT Group (BT.A) and Coats Group (COA).

Company Calendar

Last Earnings
10/01/2024
Today
3/09/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:CREO
CIK
N/A
Fax
N/A
Employees
279
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-25,038,241.40
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£33.87 million
Price / Cash Flow
2.43
Book Value
GBX 13.11 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£56.60 million
Optionable
Not Optionable
Beta
0.86
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:CREO) was last updated on 3/9/2025 by MarketBeat.com Staff
From Our Partners